Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Vivace, a San Francisco Biotech, Raises $40 Million from China-US Investors

publication date: Jun 28, 2017
Vivace Therapeutics, a Bay-area oncology company, raised a total of $40 million in venture capital from China-US investors. The Series B, which brought in $25 million, was led by new investor Cenova Capital of Shanghai and included Sequoia Capital China and existing investors Canaan Partners, WuXi Healthcare Ventures and Mission Bay Capital. The previously unannounced $15 Million A round was completed in 2015. Sofie Qiao, PhD, president and CEO of Vivace, was head of WuXi Healthcare Ventures before heading up Vivace. Vivace does some of its development work in China, most likely with WuXi AppTech. Until now, Vivace has been in stealth mode. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here